Huapont Life Sciences Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	3,966	2,858	3,290	3,783	4,187	4,386
Short-Term Investments	-	-	1,556	1,197	799.5	605.52
Trading Asset Securities	933.1	993.3	653.87	630.28	706.29	1,030
Cash & Short-Term Investments	4,899	3,852	5,500	5,610	5,692	6,022
Cash Growth	11.13%	-29.97%	-1.97%	-1.44%	-5.47%	20.81%
Accounts Receivable	2,812	2,645	2,554	2,048	2,294	2,676
Other Receivables	644.37	633.47	579	681.23	583.37	666.99
Receivables	3,456	3,279	3,133	2,729	2,877	3,343
Inventory	1,902	2,016	2,253	2,675	2,536	2,402
Prepaid Expenses	-	-	-	-	3.88	14.94
Other Current Assets	2,135	2,314	390.25	373.77	445.45	531.85
Total Current Assets	12,393	11,460	11,277	11,387	11,554	12,314
Property, Plant & Equipment	9,465	9,560	9,925	10,051	8,920	7,973
Long-Term Investments	2,424	2,430	2,474	2,894	2,940	2,534
Goodwill	1,976	1,976	2,032	2,740	2,948	3,440
Other Intangible Assets	1,537	1,549	1,526	1,599	1,733	1,724
Long-Term Deferred Tax Assets	490.16	480.17	525.93	434.04	342.15	266.23
Long-Term Deferred Charges	451.82	469.27	575.07	540.53	558.56	570.14
Other Long-Term Assets	1,093	1,105	1,116	1,082	1,033	1,218
Total Assets	29,830	29,029	29,450	30,727	30,029	30,040
Accounts Payable	1,795	1,982	2,266	2,703	2,375	2,439
Accrued Expenses	193.48	369.26	403.62	398.82	1,728	1,556
Short-Term Debt	2,996	2,895	3,561	4,666	4,576	5,493
Current Portion of Long-Term Debt	2,009	2,049	2,318	1,016	1,678	1,192
Current Portion of Leases	-	-	13.98	12.62	9.52	9.44
Current Income Taxes Payable	202.98	163.17	159.24	121.68	245.78	170.38
Current Unearned Revenue	144.65	242.03	225.51	201.39	304.6	383.17
Other Current Liabilities	1,522	1,413	1,468	1,515	193.96	146.13
Total Current Liabilities	8,862	9,113	10,415	10,634	11,112	11,389
Long-Term Debt	2,980	2,280	2,943	2,884	1,742	2,222
Long-Term Leases	51.07	46.53	53.42	47.62	41.9	51.62
Long-Term Unearned Revenue	303.44	306.8	266.87	271.23	278.21	258.13
Long-Term Deferred Tax Liabilities	104.89	110.65	104.62	111.64	109.84	103.4
Other Long-Term Liabilities	192.84	192.82	193.84	193.95	194.63	196.68
Total Liabilities	12,495	12,050	13,977	14,143	13,478	14,221
Common Stock	1,980	1,980	1,980	1,980	1,980	1,980
Additional Paid-In Capital	5,864	5,839	5,304	5,290	5,249	5,214
Retained Earnings	2,606	2,451	2,183	2,920	3,050	3,089
Treasury Stock	-30	-30	-30	-	-	-
Comprehensive Income & Other	-24.52	-20.35	-100.67	-84.95	-87.55	-176.15
Total Common Equity	10,396	10,220	9,337	10,105	10,192	10,107
Minority Interest	6,939	6,760	6,136	6,480	6,359	5,712
Shareholders' Equity	17,335	16,979	15,473	16,585	16,551	15,819
Total Liabilities & Equity	29,830	29,029	29,450	30,727	30,029	30,040
Total Debt	8,036	7,270	8,890	8,626	8,048	8,968
Net Cash (Debt)	-3,137	-3,418	-3,390	-3,016	-2,355	-2,946
Net Cash Per Share	-1.59	-1.73	-1.72	-1.52	-1.19	-1.49
Filing Date Shares Outstanding	1,972	1,973	1,973	1,976	1,980	1,980
Total Common Shares Outstanding	1,972	1,973	1,973	1,980	1,980	1,980
Working Capital	3,530	2,346	861.64	753.65	442.59	924.82
Book Value Per Share	5.27	5.18	4.73	5.10	5.15	5.10
Tangible Book Value	6,883	6,695	5,779	5,766	5,511	4,943
Tangible Book Value Per Share	3.49	3.39	2.93	2.91	2.78	2.50
Buildings	-	-	5,919	5,626	5,120	4,570
Machinery	-	-	8,462	7,632	6,765	6,051
Construction In Progress	-	-	1,154	1,869	1,434	1,464

Source: S&P Global Market Intelligence. Standard template. Financial Sources.